M. Okada et al., STUDIES ON AROMATASE INHIBITORS .3. SYNTHESIS AND BIOLOGICAL EVALUATION OF [(4-BROMOBENZYL)(4-CYANOPHENYL)AMINO]AZOLES AND THEIR AZINE ANALOGS, Chemical and Pharmaceutical Bulletin, 45(3), 1997, pp. 482-486
A series of [(4-bromobenzyl)(4-cyanophenyl)amino]azoles and their azin
e analogs, which have the side chain of the selective aromatase inhibi
tor YM511, were synthesized and evaluated for aromatase-inhibitory act
ivity (in vitro) and for pregnant mare serum gonadotropin (PMSG)-induc
ed estrogen synthesis inhibitory activity (in vivo). Among these aza-h
eterocycles, the pyrimidin-5-yl derivative (6a) was the most potent ar
omatase inhibitor and its in vitro inhibitory activity was comparable
to that of YM511. Compound 6a also showed weak inhibitory activity on
aldosterone synthesis. These data indicated that the pyrimidin-5-yl mo
iety is useful as a new azole fragment in place of the 4H-1,2,4-triazo
l-4-yl moiety of the aromatase inhibitor YM511.